Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2025-12-24 @ 9:47 PM
NCT ID:
NCT03314532
Eligibility Criteria:
Inclusion Criteria:
1. Ages 18-75 with no gender, ethnicity, religion, or geographical restrictions.
2. Diagnosed HCC patient.
3. The following criteria will be used for the evaluation of tumor resectability and adequate remaining liver volume: ≥ 30% remaining liver volume/total liver volume for non-hepatitis patients; ≥ 40% remaining liver volume/total liver volume for hepatitis patients.
4. Imaging examination with no cancer embolus above the secondary branch of the portal vein.
5. New lesions found five years after liver cancer treatment.
6. Child-Pugh A or B grade liver function.
7. No concurrent malignancies in other systems.
8. Informed subjects who fully understand and willingly cooperate with the test program with signed relevant documents.
Exclusion Criteria:
1. Suffer from other malignancies.
2. Have received any other liver cancer treatments.
3. Pathological diagnosis as non-HCC.
4. Experience large blood vessel invasion, distant metastases, or unresectable liver cancer.
5. One or more organ failures.
6. Child-Pugh C grade liver function.
7. Incomplete surgical resection or TILA-TACE.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03314532
Study Brief:
Protocol Section:
NCT03314532